5-hydroxypyrazinamide has been researched along with Liver Cirrhosis in 1 studies
*Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duwoos, H; Lacroix, C; Lafont, O; Phan Hoang, T; Tranvouez, JL | 1 |
1 other study(ies) available for 5-hydroxypyrazinamide and Liver Cirrhosis
| Article | Year |
|---|---|
Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Liver Cirrhosis; Liver Function Tests; Male; Pyrazinamide | 1990 |